Literature DB >> 15731466

William M. Feinberg Lecture: Cognitive vitality and the role of stroke and cardiovascular disease risk factors.

Philip B Gorelick1.   

Abstract

BACKGROUND AND
PURPOSE: Vascular risk factors are common in the elderly, and some such as hypertension may be important predictors of cognitive impairment. SUMMARY OF REVIEW: In this article, the role that vascular risk factors may play in the prevention of vascular and nonvascular forms of cognitive impairment is reviewed.
CONCLUSIONS: Because vascular risk factors may have negative effects on brain structure and cognitive function, and because vascular risk factors may be present in midlife or possibly earlier, we may need to develop long-term intervention strategies to control or prevent vascular risk factors in an effort to preserve cognitive vitality as we age.

Entities:  

Mesh:

Year:  2005        PMID: 15731466     DOI: 10.1161/01.STR.0000158916.59742.7c

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  13 in total

1.  Neuroanatomical correlates of fluid intelligence in healthy adults and persons with vascular risk factors.

Authors:  Naftali Raz; Ulman Lindenberger; Paolo Ghisletta; Karen M Rodrigue; Kristen M Kennedy; James D Acker
Journal:  Cereb Cortex       Date:  2007-07-05       Impact factor: 5.357

2.  Use of statins and risk of hospitalization with dementia: a Danish population-based case-control study.

Authors:  Henriette Thisted Horsdal; Anne Vingård Olesen; Christiane Gasse; Henrik Toft Sørensen; Robert C Green; Søren Paaske Johnsen
Journal:  Alzheimer Dis Assoc Disord       Date:  2009 Jan-Mar       Impact factor: 2.703

3.  Integrating health into cognitive aging: toward a preventive cognitive neuroscience of aging.

Authors:  Avron Spiro; Christopher B Brady
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2011-07       Impact factor: 4.077

4.  Dementia and Alzheimer's disease: a new direction.The 2010 Jay L. Foster Memorial Lecture.

Authors:  Lewis H Kuller; Oscar L Lopez
Journal:  Alzheimers Dement       Date:  2011-09       Impact factor: 21.566

Review 5.  Pharmacotherapy for Vascular Cognitive Impairment.

Authors:  Muhammad U Farooq; Jiangyong Min; Christopher Goshgarian; Philip B Gorelick
Journal:  CNS Drugs       Date:  2017-09       Impact factor: 5.749

Review 6.  Neurotoxic saboteurs: straws that break the hippo's (hippocampus) back drive cognitive impairment and Alzheimer's Disease.

Authors:  Mak Adam Daulatzai
Journal:  Neurotox Res       Date:  2013-07-03       Impact factor: 3.911

Review 7.  Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association.

Authors:  Philip B Gorelick; Angelo Scuteri; Sandra E Black; Charles Decarli; Steven M Greenberg; Costantino Iadecola; Lenore J Launer; Stephane Laurent; Oscar L Lopez; David Nyenhuis; Ronald C Petersen; Julie A Schneider; Christophe Tzourio; Donna K Arnett; David A Bennett; Helena C Chui; Randall T Higashida; Ruth Lindquist; Peter M Nilsson; Gustavo C Roman; Frank W Sellke; Sudha Seshadri
Journal:  Stroke       Date:  2011-07-21       Impact factor: 7.914

Review 8.  Diagnosis and management of vascular cognitive impairment.

Authors:  David L Nyenhuis; Philip B Gorelick
Journal:  Curr Atheroscler Rep       Date:  2007-10       Impact factor: 5.113

Review 9.  Vascular cognitive impairment and dementia.

Authors:  Philip B Gorelick; Scott E Counts; David Nyenhuis
Journal:  Biochim Biophys Acta       Date:  2015-12-15

10.  The inclusion of cognition in vascular risk factor clinical practice guidelines.

Authors:  Kenneth Rockwood; Laura E Middleton; Paige K Moorhouse; Ingmar Skoog; Sandra E Black
Journal:  Clin Interv Aging       Date:  2009-11-18       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.